Search Results for "Dcis Recurrence After Mastectomy"

21:13 EST 24th November 2015 | BioPortfolio

Matching Channels

Tumor recurrence


For optimal treatment in cancerology, clinicians need specific, precise, sensitive methods to quantify treatment response, monitor residual disease and detect early recurrence in patients. Residual ...

WolffParkinsonWhite WPW syndrome

Wolff–Parkinson–White syndrome (WPW) is a syndrome of pre-excitation of ventricles of the heart due to an accessory pathway known as the bundle of Kent. This accessory pathway is an abno...

UroGenRA - Genitourinary cancer array

UroGenRA is a CGI custom-designed oligonucleotide array for implementation within a clinical laboratory as an array CGH-based diagnostic/prognostic tool for kidney, prostate, and bladder cancers. It...

Tumor markers

Tumor markers are substances produced by tumor cells or by other cells of the body in response to cancer or certain benign (noncancerous) conditions. These substances can be found in the blood, in t...

Matching News

Molecular Phenotypes of DCIS Predict Recurrence

Find out what types of recurrence are predicted and why it matters. Annals of Oncology

New Data on DCIS Recurrence Good News for Patients Electing Breast-Conserving Surgery

Our study shows a declining rate of recurrence over the decades, suggesting that for a woman treated today, the expected recurrence rate should be lower than that seen in the randomized trials.

Breast Cancer Research and Treatment Publishes Oncotype DX DCIS Score Study Conducted in Canada

Genomic Health has announced that Breast Cancer Research and Treatment published results from a second large clinical validation study of Oncotype DX in patients with stage 0 breast cancer, also known...

Treatment patterns for DCIS shift from 1991 to 2010

(HealthDay)—There were substantial shifts in treatment patterns for ductal carcinoma in situ (DCIS) from 1991 to 2010, with more women opting for lumpectomy and radiation therapy rather than single ...

Breast Cancer Research and Treatment Publishes Oncotype DX® DCIS Score™ Study

REDWOOD CITY, Calif., July 14, 2015 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that Breast Cancer Research and Treatment published results from a second large clinical va...

DCIS Recurrence Rates Cut in Half

Five-year recurrence rates for women with ductal carcinoma in situ have been cut in half recently due to advances in mammography and more detailed pathology assessments.

Single Mastectomy Saves Money Compared With Double Mastectomy

An analysis of outcomes over 10 years suggests that single mastectomy is cheaper and improves quality of life when compared with contralateral prophylactic mastectomy. Medscape Medical News

Oncotype DX® Presentations at ASCO in Breast and Prostate Cancer Reinforce Genomic Health's Leadership in Optimizing Cancer Treatment

REDWOOD CITY, Calif., June 1, 2015 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced results from multiple Oncotype DX® studies presented at the 2015 American Society of Cl...

Matching PubMed Articles

The locoregional recurrence post-mastectomy for ductal carcinoma in situ: Incidence and risk factors.

The objective of this retrospective study was to determine the incidence of recurrence of breast cancer after mastectomy for ductal carcinoma in situ (DCIS) in our institution, and to evaluate the ass...

How different terminology for ductal carcinoma in situ (DCIS) impacts women's concern and management preferences: A qualitative study.

There are increasing rates of mastectomy and bi-lateral mastectomy in women diagnosed with ductal carcinoma in situ (DCIS). To help women avoid decisions that lead to unnecessary aggressive treatments...

Factors Affecting Informed Decision-Making in Women with Increased Breast Cancer Risk or DCIS Pursuing Contralateral Prophylactic Mastectomy.

Despite lack of survival benefit, an increasing number of women diagnosed with ductal carcinoma in situ (DCIS) opt for removal of the unaffected breast in addition to the breast with known pathology, ...

Chest wall recurrence location and the lower-bound target of preventive radiotherapy after transverse incision in modified radical mastectomy.

We investigated the relationship between the lower-bound target of preventive radiation to the chest wall after modified radical mastectomy with a transverse incision and preoperative breast carcinoma...

Genomic differences between pure ductal carcinoma in situ and synchronous ductal carcinoma in situ with invasive breast cancer.

Although ductal carcinoma in situ (DCIS) precedes invasive ductal carcinoma (IDC), the related genomic alterations remain unknown. To identify the genomic landscape of DCIS and better understand the m...

Search Whole site using Google


Advertisement Advertisement